Mesothelioma Foundation Experts Can Answer Your Questions!

The Mesothelioma Applied Research Foundation's team of experts is available to answer your questions about mesothelioma, its symptoms and treatments as well as options available to you. This help is a free service. We are not a law firm. Read more about the Mesothelioma Applied Research Foundation.

TO GET HELP CALL: (877) End-Meso or (877) 363-6376 or fill out the form to the right to be contacted by us.

Facebook Twitter YouTube Google Plus

E.) Navigating Mesothelioma Clinical Trials with GPS (Getting Personalized Service)

Robert N. Taub, MD, PhD
Columbia University Medical Center

Dr. Robert Taub is Vivian and Seymour Milstein Family Professor of Clinical Medicine, Columbia College of Physicians and Surgeons; Director, Columbia University Mesothelioma Center; and Attending Oncologist, Columbia University Medical Center. He is a medical oncologist and hematologist with a special interest in the diagnosis, clinical care, and investigation of patients with malignant mesothelioma and soft tissue sarcoma. The Columbia Mesothelioma Center under Dr. Taub’s direction is developing unique new treatment algorithms utilizing intracavitary chemotherapy for multimodal treatment of abdominal mesothelioma and for lung-sparing treatment of pleural mesothelioma. Dr Taub’s interests are in investigator-initiated cell-biology based laboratory and translational studies in mesothelioma and soft tissue sarcoma, in collaboration with the Comprehensive Cancer Center and the Departments of Surgery and Pathology, as a means of optimizing the clinical care that he and his colleagues directly provide to these patients.
 


Click here to view the slides for "Navigating Mesothelioma Clinical Trials with GPS (Getting Personalized Service) by Robert Taub, MD, PhD.

To view the video presentation, please click on the below image.

© 2009 Mesothelioma Applied Research Foundation, Inc. All rights reserved. 501(c)(3)

A.) Effective Advocacy and the Case for Federal Meso Research Funding

B.) State Assistance on Insurance Appeals

C.) Cancer Genetics in the Mesothelioma Family

D.) Fundraising

E.) Navigating Mesothelioma Clinical Trials with GPS (Getting Personalized Service)

F.) Update from Across the Pond

G.) The Mesothelioma Experience: Patient and Provider Perspectives Panel

H.) Work of the Science Advisory Board

J.) Present and Future of Mesothelioma Treatment: Medical Oncologist and Researcher Perspective

K.) New Developments in Radiation Oncology: A Global Perspective

M.) Pain Management

Mesothelioma Treatment: Present & Future from a Surgeon & Research Perspective | Dr. Harvey Pass

N.) Traditional Healing with Modern Science

O.) Update on Clinical Trials and Mesothelioma Research

P.) Mesothelioma Tissue Bank

Photodynamic Therapy for Mesothelioma Treatment | Dr. Joseph Friedberg

Q.) EGFR Inhibitors for Patients with Malignant Peritoneal Mesothelioma

R.) The Use of Cytokine Inhibitors: Translational Lab Results

S.) Identifying and Targeting Aggressive Malignant Peritoneal Mesothelioma: Morphologic and Molecular Studies

T.) Treatment Options for Patients with Recurrent Disease after HIPEC, HRA - Panel Discussion